Merck KGaA's stock remains a 'hold' due to its high valuation, trading at an earnings multiple of around 20 and a 4.5% free ...

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas ...

Let's take a look at what these Wall Street heavyweights have to say about Merck (MRK) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.

Merck (MRK) reported Q3 EPS of $1.85, $0.10 better than the analyst estimate of $1.75. Revenue for the quarter came in at $15 ...

Investors in Merck & Co Inc (Symbol: MRK) saw new options begin trading today, for the April 11th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRK ...

Merck (MRK) announced results from the Phase 3 KEYNOTE-966 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, in combination ...

propelling the micro-cap biotech stock into the top 10 trending symbols on Stocktwits. The company is set to receive a $15 million milestone payment from Merck, triggered by the latter's ...